Consistently, tumor growth suppression induced by Prame downregulation was rescued by simultaneous downregulation of p14/ARF, suggesting the inhibitory effect of targeting Prame on tumor formation was mediated by p14/ARF accumulation (Fig. 6G–I). The gene discussed is CDKN2A; the disease is neoplasm.